Table 2 Biomarkers levels and risk of disease status.

From: Biomarker potential of vanin-1-derived pantothenic acid in diabetes and its associated cardiovascular complications

Disease status

Biomarkers level

OR (95% confidence

interval)

P-value

Obesity

Vanin-1 > 1.574 ng/ml

0.637

(0.17–2.28)

0.489

Pantothenic acid 

< 850.27 ng/ml

2.853

(0.51–15.99)

0.233

Diabetes in patients

without obesity

Vanin-1 > 1.574 ng/ml

0.664

(0.11–3.81)

0.642

Pantothenic acid 

< 850.27 ng/ml

5.124

(0.73–35.73)

0.099

Diabetes in patients

with obesity

Vanin-1 > 1.574 ng/ml

2.146

(0.59–7.57)

0.235

Pantothenic acid 

< 850.27 ng/ml

7.610

(1.37–42.05)

0.02

Diabetes with CVD in

patients without obesity

Vanin-1 > 1.574 ng/ml

1.616

(0.363–7.19)

0.529

Pantothenic acid

 < 850.27 ng/ml

7.237

(1.11–47.10)

0.038

Diabetes with CVD in

patients with obesity

Vanin-1 > 1.574 ng/ml

1.326

(0.349–5.03)

0.679

Pantothenic acid

 < 850.27 ng/ml

12.028

(2.23–64.76)

0.004

  1. Significant values are in [bold].
  2. CVD, cardiovascular disease; OR, odds ratio.